Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

Inclusion Criteria: * Subject or legally authorized representative must be able to understand and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent form. * Subject must have had bilateral implantation of AcrySof PanOptix and/or AcrySof PanOptix Toric IOL models for 3 to 5 years prior to enrollment. A subject may have a toric lens in one eye and a non-toric in the fellow eye. * Subject must have a documented medical history and required pre-operative baseline information available for retrospective data collection. Exclusion Criteria: * Subject currently participating in another investigational drug or device study. * Subject has had corneal refractive surgery after AcrySof PanOptix or AcrySof PanOptix Toric IOL implantation. * Subject exposed to a study IOL for a minimum of 3 years prior to Visit 1 that have subsequently undergone an IOL exchange and are no longer implanted with a study IOL at the time of enrollment. * Subject is pregnant or nursing at the time of enrollment.